MedTrace Logo

Electrophysiological Biomarkers in MTLE Patients.

NCT04710004 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1

Last updated 2024-03-05

Study results available
· View outcomes & findings →

Summary

The investigators plan to enroll individuals with medical temporal lobe epilepsy who are undergoing surgical workup with clinically implanted intracranial electrodes. The study intends to administer computerized memory tasks and stimulation during the intracranial Electroencephalography (EEG) monitoring period.

Conditions

  • Mesial Temporal Lobe Epilepsy

Interventions

DEVICE

Asynchronous distributed multi-electrode stimulation (ADMES) using an implantable neurostimulation device

Participants will receive asynchronous pulses distributed across a multi-electrode array of 16 micro-electrodes and stimulating at low (theta) frequencies.

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Robert Gross, MD · Emory University

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-30
Primary Completion
2021-12-16
Completion
2021-12-16
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04710004 on ClinicalTrials.gov